Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|May 26, 2019
Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro StudySara G Creemers, Richard A Feelders, Frank H de Jong, et al.
Biomedicines|March 25, 2022
The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System ActivationAmber Blaauboer, Peter M van Koetsveld, Dana A M Mustafa, et al.
Cancer Research|January 7, 2006
IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitroGiovanni Vitale, Wouter W de Herder, Peter M van Koetsveld, et al.
American Journal of Veterinary Research|September 5, 2006
Effects of food intake and food withholding on plasma ghrelin concentrations in healthy dogsSofie F Bhatti, Leo J Hofland, Peter M van Koetsveld, et al.
Neuroendocrinology|July 19, 2019
Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor CellsAura D Herrera-Martínez, Richard A Feelders, Rosanna Van den Dungen, et al.
Oncotarget|March 31, 2018
Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cellsMarije J Veenstra, Peter M van Koetsveld, Fadime Dogan, et al.
American Journal of Cancer Research|July 10, 2023
Rintatolimod: a potential treatment in patients with pancreatic cancer expressing Toll-like receptor 3Hassana El Haddaoui, Casper Wf van Eijck, Michail Doukas, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Melanocortin 2 receptor-associated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsivenessJohannes Hofland, Patric J Delhanty, Jacobie Steenbergen, et al.
Pageof 7